These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Attenuation of endothelin-1 induced vasoconstriction by 17beta estradiol is not sustained during long-term therapy in postmenopausal women with coronary heart disease. Jhund PS; Dawson N; Davie AP; Sattar N; Norrie J; O'Kane KP; McMurray JJ J Am Coll Cardiol; 2001 Apr; 37(5):1367-73. PubMed ID: 11300448 [TBL] [Abstract][Full Text] [Related]
44. Relationship between the angiotensin-converting enzyme genotype and the forearm vasodilator response to estrogen replacement therapy in postmenopausal women. Sanada M; Higashi Y; Nakagawa K; Sasaki S; Kodama I; Tsuda M; Nagai N; Ohama K J Am Coll Cardiol; 2001 May; 37(6):1529-35. PubMed ID: 11345361 [TBL] [Abstract][Full Text] [Related]
45. Statin therapy increases vascular sensitivity to angiotensin II in hypercholesterolaemic patients. Sim JS; Dick JB; Struthers AD J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):109-13. PubMed ID: 15526245 [TBL] [Abstract][Full Text] [Related]
46. Estrogen replacement therapy in postmenopausal women augments reactive hyperemia in the forearm by reducing angiotensin converting enzyme activity. Sanada M; Higashi Y; Nakagawa K; Sasaki S; Kodama I; Sakashita T; Tsuda M; Ohama K Atherosclerosis; 2001 Oct; 158(2):391-7. PubMed ID: 11583718 [TBL] [Abstract][Full Text] [Related]
47. Effects of hormone therapy on blood pressure and the renin-angiotensin system in postmenopausal women. Prime DD; Brosnihan KB; Herrington DM Minerva Cardioangiol; 2007 Aug; 55(4):477-85. PubMed ID: 17653023 [TBL] [Abstract][Full Text] [Related]
48. The vascular protective role of oestradiol: a focus on postmenopausal oestradiol deficiency and aneurysmal subarachnoid haemorrhage. Ramesh SS; Christopher R; Indira Devi B; Bhat DI Biol Rev Camb Philos Soc; 2019 Dec; 94(6):1897-1917. PubMed ID: 31264341 [TBL] [Abstract][Full Text] [Related]
49. 17ss oestradiol does not attenuate the response to angiotensin I and II during long term therapy in postmenopausal women. Jhund PS; Dawson N; Davie AP; Norrie J; O'Kane KP; McMurray JJ Cardiovasc Drugs Ther; 2004 Jan; 18(1):31-6. PubMed ID: 15115901 [TBL] [Abstract][Full Text] [Related]